BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2231674)

  • 1. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bactericidal activity of sparfloxacin.
    Lewin CS; Morrissey I; Smith JT
    J Antimicrob Chemother; 1992 Nov; 30(5):625-32. PubMed ID: 1337350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
    Lewin CS
    J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
    Morrissey I; Smith JT
    J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of trovafloxacin (CP-99,219).
    Morrissey I
    J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
    Feng P; Yu R; Xia P; Lü X; Zhu S
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of PD127,391, a new quinolone.
    King A; Boothman C; Phillips I
    J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
    Asuquo AE; Piddock LJ
    J Antimicrob Chemother; 1993 Jun; 31(6):865-80. PubMed ID: 8360125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Quinolone bactericidal mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis.
    Parte AC; Smith JT
    Microbios; 1994; 79(319):87-95. PubMed ID: 7968664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolones in sweat and quinolone resistance.
    Hawkey PM
    Lancet; 1997 Jan; 349(9046):148-9. PubMed ID: 9111534
    [No Abstract]   [Full Text] [Related]  

  • 15. Bactericidal mechanism of gatifloxacin compared with other quinolones.
    Gradelski E; Kolek B; Bonner D; Fung-Tomc J
    J Antimicrob Chemother; 2002 Jan; 49(1):185-8. PubMed ID: 11751786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
    Anderson R; Jooné GK
    Chemotherapy; 1993; 39(6):424-31. PubMed ID: 8222871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.
    Lewin CS; Amyes SG
    J Med Microbiol; 1989 Nov; 30(3):227-31. PubMed ID: 2479750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan films are NOT antimicrobial.
    Foster LJ; Butt J
    Biotechnol Lett; 2011 Feb; 33(2):417-21. PubMed ID: 20953663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of fluoroquinolones in combination with zidovudine.
    Lewin CS; Allen RA; Amyes SG
    J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.